CYP2D6 and cancer: In contrast, the anti-cancer drug tamoxifen had 10-fold fewer prescriptions; thus, screening CYP2D6 for high-frequency alleles (*29, *17, *10, *41) would result in tangible benefits for patient’s clinical outcomes.